Hellometer vs Moderna

Side-by-side comparison of AI visibility scores, market position, and capabilities

Moderna leads in AI visibility (90 vs 37)
Hellometer logo

Hellometer

EmergingHealthcare

General

Employee mental health measurement and wellbeing platform for SMB employers with anonymized workforce assessments; $150K YC W20-backed competing with Lyra and Modern Health in employer mental health benefits.

AI VisibilityBeta
Overall Score
D37
Category Rank
#495 of 596
AI Consensus
74%
Trend
stable
Per Platform
ChatGPT
42
Perplexity
31
Gemini
35

About

Hellometer is a Santa Monica-based employee wellbeing and mental health platform founded in 2020 that provides businesses with tools to measure and improve workforce mental health — offering wellbeing assessments, resources, and manager tools that help companies understand the mental health status of their workforce and provide appropriate support. Backed by Y Combinator (W20) with $150,000 from investors including LAUNCH Fund, Intel Ignite, and Bling Capital, Hellometer operates in the growing employer mental health benefits market.

Full profile
Moderna logo

Moderna

LeaderHealthcare Tech

Enterprise

mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.

AI VisibilityBeta
Overall Score
A90
Category Rank
#2 of 596
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
92
Perplexity
93
Gemini
89

About

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.

Full profile

AI Visibility Head-to-Head

37
Overall Score
90
#495
Category Rank
#2
74
AI Consensus
83
stable
Trend
stable
42
ChatGPT
92
31
Perplexity
93
35
Gemini
89
34
Claude
96
39
Grok
95

Key Details

Category
General
Enterprise
Tier
Emerging
Leader
Entity Type
brand
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.